Near-infrared Fluorescence Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose Second Window Indocyanine Green Technique: a Multicenter Randomized Controlled Trial
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 592
- 主要终点
- 2-year local recurrence rate
研究概览
简要总结
This research study will evaluate how near-infrared fluorescence (NIRF) imaging with low-dose second window indocyanine green (ICG) can assist in the radical resection and pathologic diagnosis of malignant soft tissue sarcoma, such as dermatofibrosarcoma protuberans (DFSP) and skin squamous cell carcinoma (sSCC) during surgery.
详细描述
To improve the accuracy of radical resection by reducing the risk of missed diagnosis of positive margin, this study will explore clinical application of near-infrared fluorescence imaging with modified low-dose SWIG technique in guiding radical resection of malignant soft tissue tumor. The investigators conduct a multi-center, multi-subgroup, prospective randomized controlled trial. The participants will be first stratified according to histological type involving dermatofibrosarcoma protuberans (DFSP) and skin squamous cell carcinoma (sSCC). The patients with DFSP or sSCC will be then randomly assigned to three groups. Patients in the control group will not receive ICG administration. The ICG was injected intravenously 24 hours before surgery, at a dose of 0.25 mg/kg in the first experimental group and 25 mg/patient in the second experimental group, respectively. The patients in the control groups will undergo traditional assessment of surgical margins.The patients in the experimental groups, on the other hand, will be scheduled to intraoperative near-infrared fluorescence imaging to scan gross tumor, tumor bed and cross-sectional specimen. The 2-year local recurrence rate will be regarded as primary outcome. The number of positive margins will be compared among groups. The investigators will also calculate the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) with 95% confidence intervals based on fluorescent signal of tumor bed in the experimental groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with DFSPs or sSCC in heads, extremities or trunk
排除标准
- •seafood/iodine allergy
- •hyperthyroidism
- •pregnancy
- •myasthenia gravis
- •acute severe hypertension
研究组 & 干预措施
Patients with DFSP in the first experimental group
The ICG was injected intravenously 24 hours before surgery at a dose of 0.25 mg/kg in the first experimental group.
干预措施: ICG administration (Drug)
Patients with DFSP in the second experimental group
The ICG was injected intravenously 24 hours before surgery at a dose of 25 mg/patient in the second experimental group.
干预措施: ICG administration (Drug)
Patients with sSCC in the first experimental group
The ICG was injected intravenously 24 hours before surgery at a dose of 0.25 mg/kg in the first experimental group.
干预措施: ICG administration (Drug)
Patients with sSCC in the second experimental group
The ICG was injected intravenously 24 hours before surgery at a dose of 25 mg/patient in the second experimental group.
干预措施: ICG administration (Drug)
结局指标
主要结局
2-year local recurrence rate
时间窗: up to 24 months
次要结局
- number of positive margins(through study completion, an average of 2 years)
- sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV)(through study completion, an average of 2 years)
- Adverse effects(through study completion, an average of 2 years)
研究者
Lei Cui
Principal Investigator
The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
